The Intercept @theintercept
An academic who favors pharmaceutical monopoly rights, leads an institute at Duke University funded by Pfizer and AstraZeneca. The apparent conflict of interest is hardly a rare occurrence. https://t.co/NG5TEGKxhC — PolitiTweet.org